NewMed Energy (NWMD) Corporate presentation summary

Strategic positioning and asset portfolio

• Operates across the full exploration and production value chain with a $7 billion market cap and is listed on the TA-35 index.

• Holds a world-class portfolio, evolving from domestic to regional dominance and pursuing global expansion.

• Financial strength is underpinned by robust cash flow and valuable assets.

Leviathan project overview

• Holds a 45.3% stake in Leviathan, a major regional gas asset with 2P reserves of 19.5 tcf and 43 mmbbl condensate.

• Production capacity is expanding from 1.2 bcf/d to over 2.1 bcf/d, with additional prospective oil resources.

• Long-term contracts with take-or-pay mechanisms and limited price risk support stable revenues.

• Sales are diversified across Israel, Egypt, and Jordan, with increasing contracted volumes through 2030.

Financial and operational performance

• Net production from Leviathan averaged 5.0–6.2 bcm annually (2022–2025), with realized prices rising from $0.73 to $0.93/mmbtu.

• Net revenue ranged from $1,011 million to $1,144 million, and EBITDA from $684 million to $813 million (2022–2025).

• Average operating expenses remained stable at $0.84/mcf.